Skip to content
Clinical Trials – home

Region Gaevleborg

Verified siteinfo

Sweden Rektorsgatan 1, 802 50 Gavle, Sweden

  • 20 trials recruiting
  • Non-small cell lung cancer · Non-small cell lung cancer metastatic · Breast cancer
  • Adults and children

About Specializations

Region Gaevleborg in Gavle, Sweden specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer metastatic, Breast cancer, Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Cancer Research at Region Gaevleborg

Clinical trials at this hospital-based site focus on neoplasms, with research centered on improving care for people with cutaneous malignant melanoma and small cell lung cancer. The studies are designed to evaluate new treatment approaches and better define how long immunotherapy should be used after surgery or alongside other cancer treatments.

  • Testing whether shorter immunotherapy can provide similar benefit after surgery for high-risk melanoma
  • Comparing combination treatment strategies for advanced small cell lung cancer against standard chemotherapy
  • Assessing treatment effectiveness and survival outcomes in patients with advanced cancer

This work reflects a focused oncology program in Gavle that aims to improve survival and refine treatment choices for patients with difficult-to-treat cancers.

Lungenheten Cancer Studies in Sweden

At Lungenheten, the clinical trial portfolio is concentrated in oncology, with particular attention to skin cancer and lung cancer. The research is exploring whether newer treatment combinations can improve outcomes, while also helping clinicians understand the most effective duration and use of cancer therapy.

  • Cutaneous malignant melanoma studies examining post-surgery immunotherapy
  • Small cell lung cancer research evaluating a new treatment combination for advanced disease
  • Clinical efforts aimed at improving overall survival and treatment effectiveness

With a small but targeted set of trials, the site contributes to practical advances in cancer care for patients in the Region Gaevleborg area.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Rektorsgatan 1802 50 GavleSweden
Recruiting now
20 trials
Conditions studied
35
Partner status
Verified site

More sites in GavleSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

40 clinical trials

Colorectal cancer+2

Recruiting

Study of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Revolution Medicines Inc.

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.

Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Aciclovir sodium
  • Sponsor:Region Uppsala
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ciprofloxacin
  • Sponsor:Region Uppsala

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF

Study on EGFR-Mutated Lung Cancer: Evaluating Dacomitinib, Afatinib, and Osimertinib for Patients Not Suitable for Curative Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Region Skane

Diabetic foot

Recruiting

Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.